Alvina A Acquaye1, Lin Lin1, Elizabeth Vera-Bolanos1, Mark R Gilbert1, Terri S Armstrong1. 1. Department of Family Health, University of Texas Health Science Center School of Nursing, Houston, Texas (A.A.A.); Department of Family Health, The University of California, San Francisco, California (L.L.); Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas (E.V.-B., T.S.A.); Department of Neuro-Oncology, National Institutes of Health, Bethesda, Maryland (M.R.G.); Department of Family Health, University of Texas Health Science Center School of Nursing, Houston, Texas (T.S.A.).
Abstract
BACKGROUND: The ambiguity of defining hope impacts the level of readiness faced by health care professionals treating patients with glioma, a disease with unpredictable outcomes. This study describes the report of hope and the relationship between hope and mood in adult brain tumor patients at various points in the illness trajectory. METHODS: This was a cross-sectional study with data collection including use of the Herth Hope Index (HHI), the Profile of Mood States-Short Form (POMS-SF), and clinical information. Descriptive statistics were used to report sample characteristics. Spearman's rho and Mann-Whitney tests were used to compare and differentiate scores. RESULTS: Eighty-two patients ranging in age from 22 to 78 years (median, 44.5 y) participated in the study. Patients were primarily male (57.3%), married (76.8%), and had a high-grade glioma (35.4%). Nearly half had recurrence, and more than 20% were on active treatment. The overall HHI total score for the sample was 41.32 (range: 13-48). Patients with recurrence had a lower HHI interconnectedness (median = 14.00) score and higher total mood disturbance (median = 14.00) compared with patients without recurrence (median = 15.00 and median = 0.00, respectively; P < .05). All negative mood states on the POMS-SF were negatively correlated with HHI subscales. CONCLUSIONS: Overall, patients reporting more hope also reported less overall mood disturbance As expected, patients with tumor recurrence reported lower hope and higher mood disturbance than those who were newly diagnosed or without recurrence. Targeting interventions specifically tailored to an individual's needs for improvement in quality of life throughout the disease course may include measures to address hope in order to facilitate positive coping strategies.
BACKGROUND: The ambiguity of defining hope impacts the level of readiness faced by health care professionals treating patients with glioma, a disease with unpredictable outcomes. This study describes the report of hope and the relationship between hope and mood in adult brain tumorpatients at various points in the illness trajectory. METHODS: This was a cross-sectional study with data collection including use of the Herth Hope Index (HHI), the Profile of Mood States-Short Form (POMS-SF), and clinical information. Descriptive statistics were used to report sample characteristics. Spearman's rho and Mann-Whitney tests were used to compare and differentiate scores. RESULTS: Eighty-two patients ranging in age from 22 to 78 years (median, 44.5 y) participated in the study. Patients were primarily male (57.3%), married (76.8%), and had a high-grade glioma (35.4%). Nearly half had recurrence, and more than 20% were on active treatment. The overall HHI total score for the sample was 41.32 (range: 13-48). Patients with recurrence had a lower HHI interconnectedness (median = 14.00) score and higher total mood disturbance (median = 14.00) compared with patients without recurrence (median = 15.00 and median = 0.00, respectively; P < .05). All negative mood states on the POMS-SF were negatively correlated with HHI subscales. CONCLUSIONS: Overall, patients reporting more hope also reported less overall mood disturbance As expected, patients with tumor recurrence reported lower hope and higher mood disturbance than those who were newly diagnosed or without recurrence. Targeting interventions specifically tailored to an individual's needs for improvement in quality of life throughout the disease course may include measures to address hope in order to facilitate positive coping strategies.
Authors: Lin Lin; Hui-Hsun Chiang; Alvina A Acquaye; Elizabeth Vera-Bolanos; Mark R Gilbert; Terri S Armstrong Journal: Cancer Date: 2013-05-09 Impact factor: 6.860
Authors: Wendy Duggleby; Allison Williams; Lorraine Holstlander; Dan Cooper; Sunita Ghosh; Lars K Hallstrom; Roanne Thomas McLean; Mary Hampton Journal: BMC Palliat Care Date: 2013-10-09 Impact factor: 3.234
Authors: Terri S Armstrong; Marcia Y Shade; Ghislain Breton; Mark R Gilbert; Anita Mahajan; Michael E Scheurer; Elizabeth Vera; Ann M Berger Journal: Neuro Oncol Date: 2017-03-01 Impact factor: 12.300
Authors: Bożena Baczewska; Bogusław Block; Mariola Janiszewska; Krzysztof Leśniewski; Agnieszka Zwolak Journal: Int J Environ Res Public Health Date: 2022-08-13 Impact factor: 4.614
Authors: Caroline Arbour; Marjorie Tremblay; David Ogez; Chloé Martineau-Lessard; Gilles Lavigne; Pierre Rainville Journal: Support Care Cancer Date: 2021-08-10 Impact factor: 3.603